Open AccessVEGF as a Survival Factor in Ex Vivo Models of Early Diabetic Retinopathy
Author(s) -
Rosario Amato,
Martina Biagioni,
Maurizio Cammalleri,
Massimo Dal Monte,
G. Casini
Publication year - 2016
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.16-19285
Subject(s) - diabetic retinopathy , ex vivo , medicine , vegf receptors , ophthalmology , in vivo , diabetes mellitus , endocrinology , biology , genetics
Growing evidence indicates neuroprotection as a therapeutic target in diabetic retinopathy (DR). We tested the hypothesis that VEGF is released and acts as a survival factor in the retina in early DR.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom